Relevium Technologies Inc. (RLLVF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $1.98M is the value of all shares combined. Beta 2.51: the stock has moved about 151% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRelevium Technologies Inc. (RLLVF) trades at $0.006. Relevium Technologies Inc. operates in the health and wellness e-commerce sector, focusing on dietary supplements and nutraceuticals. The company markets its products through various brands targeting different demographics. Market cap: $1.98M, Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for RLLVF: RLLVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Relevium Technologies Inc. (RLLVF) Healthcare & Pipeline Overview
Relevium Technologies Inc. participates in the health and wellness e-commerce market, offering dietary supplements, nutraceuticals, and skincare products through its brand portfolio. The company targets various demographics with brands like Bioganix, LeefyLyfe, and Relevium Senior, focusing on online sales and brand acquisition.
What Is the Investment Thesis for RLLVF?
Relevium Technologies Inc. operates in the growing health and wellness e-commerce market. The company's focus on brand acquisition and online sales provides a scalable business model. However, the company's negative profit margin of -587.6% raises concerns about its financial sustainability. A potential growth catalyst is the increasing demand for online health and wellness products, particularly among the senior and pediatric demographics targeted by the Relevium Senior and Relevium Kids brands. The company's high beta of 2.51 suggests significant volatility, which could present both opportunities and risks for investors. The ability to improve profitability and effectively manage its brand portfolio will be critical for long-term success.
Based on FMP financials and quantitative analysis
RLLVF Key Highlights
Market Cap of $1.98M indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of -0.32 reflects negative earnings, suggesting the company is not currently profitable.
- Profit Margin of -587.6% indicates significant losses and potential financial instability.
- Gross Margin of 45.4% shows a reasonable ability to generate profit from sales before operating expenses.
- Beta of 2.51 suggests the stock is highly volatile compared to the market.
Who Are RLLVF's Competitors?
RLLVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BCCOY BICO Group AB (publ) | $0.51 | 0.00% | $143M | — |
| BRSYF BrainsWay Ltd. | $12.60 | -16.72% | $506M | — |
| CYBQF CYBERDYNE Inc. | $1.50 | 0.00% | $200M | — |
| MEDS TRxADE HEALTH, Inc. | $3.68 | -9.36% | $9.65M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | 33 5-pillar |
| NEUP Neuphoria Therapeutics Inc. | $3.47 | -1.14% | $18.8M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RLLVF's Key Strengths?
Diverse brand portfolio targeting various health and wellness needs.
- Focus on e-commerce provides scalability and reach.
- Specialized brands cater to specific demographic segments (e.g., Relevium Senior, Relevium Kids).
- Experienced management team with a track record in brand acquisition and operation.
What Are RLLVF's Weaknesses?
Negative profit margin indicates financial instability.
- High beta suggests significant stock volatility.
- Limited brand recognition compared to larger competitors.
- Dependence on online sales channel may limit market reach.
What Are the Key Risks for RLLVF?
Financial-distress signal — its Altman Z-Score of -1.89 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Negative profit margin indicates financial instability and potential need for additional financing.
- High beta suggests significant stock volatility and sensitivity to market fluctuations.
- Intense competition from established players in the health and wellness market.
- Changing consumer preferences and trends in the dietary supplements industry.
- Regulatory changes affecting the marketing and sale of health and wellness products.
What Are RLLVF's Competitive Advantages?
- Brand Portfolio: A diverse portfolio of brands targeting different segments of the health and wellness market.
- E-commerce Focus: Specialization in online sales and marketing provides a scalable business model.
- Targeted Brands: Brands like Relevium Senior and Relevium Kids cater to specific demographic needs.
What Does RLLVF Do?
Relevium Technologies Inc., formerly known as BIOflex Technologies Inc., was rebranded in December 2015 to reflect its strategic shift towards the health and wellness market. The company identifies, evaluates, acquires, and operates brands and businesses within this sector, with a strong emphasis on e-commerce. Relevium's core business revolves around marketing a range of health and wellness products, including dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals. These products are primarily sold online through its Bioganix brand portfolio. In addition to Bioganix, Relevium markets dietary supplements under the LeefyLyfe brand name and skin care products under the Push & Pull System brand. The company also caters to specific demographic segments with its Relevium Senior brand, which targets inflammatory conditions in geriatric patients, such as joint pain, heart health, and brain function. Furthermore, Relevium Kids offers a line of nutraceuticals and oral nutritional supplements designed for pediatric use. Headquartered in Montreal, Canada, Relevium Technologies Inc. aims to expand its presence in the health and wellness market through strategic brand acquisitions and effective online marketing strategies.
What Products and Services Does RLLVF Offer?
- Identifies and evaluates potential brands and businesses in the health and wellness market.
- Acquires and operates brands within the dietary supplements, nutraceuticals, and cosmeceuticals sectors.
- Markets products primarily through its Bioganix brand portfolio online.
- Offers dietary supplements under the LeefyLyfe brand.
- Provides skin care products under the Push & Pull System brand.
- Offers Relevium Senior, a geriatric brand targeting inflammatory conditions.
- Provides Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements.
How Does RLLVF Make Money?
- Acquires and operates health and wellness brands with a focus on e-commerce.
- Generates revenue through the online sale of dietary supplements, nutraceuticals, and skincare products.
- Targets specific demographic segments with specialized brands like Relevium Senior and Relevium Kids.
What Industry Does RLLVF Operate In?
Relevium Technologies Inc. operates within the competitive health and wellness market, which is experiencing growth driven by increasing consumer awareness and a shift towards online purchasing. The competitive landscape includes established players like BCCOY (Bausch Health Companies Inc.) and smaller, niche brands. Relevium's success depends on its ability to differentiate its products, effectively market to its target demographics, and manage its operational costs to achieve profitability.
Who Are RLLVF's Key Customers?
- Health-conscious consumers seeking dietary supplements and nutraceuticals.
- Individuals looking for skincare products.
- Geriatric patients seeking products for inflammatory conditions.
- Parents seeking nutritional supplements for their children.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Relevium Technologies Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Montreal, CA. The company is led by CEO Aurelio Useche. RLLVF has traded publicly since 2017.
How Relevium Technologies Inc. Is Valued
Relevium Technologies Inc. carries a market capitalization of $1.98M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for Relevium Technologies Inc. stands at 221.4%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -4.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Relevium Technologies Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.89 places it in the distress zone, a signal of elevated financial risk.
RLLVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
RLLVF Latest News
No recent news available for RLLVF.
RLLVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RLLVF.
Price Targets
Wall Street price target analysis for RLLVF.
RLLVF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RLLVF; grades run from A+ (80-100) to F (below 30).
Leadership: Aurelio Useche
CEO
Aurelio Useche serves as the CEO of Relevium Technologies Inc. His background includes experience in the health and wellness industry, with a focus on brand development and marketing. He has been instrumental in guiding Relevium's strategic shift towards e-commerce and brand acquisition. Useche's expertise lies in identifying and integrating complementary brands into the company's portfolio, driving revenue growth and expanding market reach. Prior to joining Relevium, he held leadership positions in various consumer goods companies.
Track Record: Under Aurelio Useche's leadership, Relevium Technologies Inc. has focused on expanding its brand portfolio through strategic acquisitions. He has overseen the development and marketing of key brands, including Bioganix, LeefyLyfe, and Relevium Senior. A key achievement has been the company's transition to a predominantly e-commerce business model. However, the company's profitability remains a challenge.
RLLVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Relevium Technologies Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The lack of comprehensive financial reporting increases the risk of investing in RLLVF.
- Low Liquidity: The low trading volume can make it difficult to buy or sell shares without affecting the price.
- Regulatory Scrutiny: OTC stocks are subject to less regulatory oversight than those listed on major exchanges.
- Price Volatility: The stock may experience significant price fluctuations due to limited trading activity and information availability.
- Potential for Fraud: The OTC market has a higher risk of fraudulent activity compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and earnings growth potential.
- Check for any legal or regulatory issues.
- Monitor the stock's trading volume and price volatility.
- Consult with a qualified financial advisor.
- Established Business Operations: Relevium Technologies Inc. has been operating in the health and wellness market since 2015.
- Brand Portfolio: The company has a portfolio of brands targeting different segments of the market.
- E-commerce Focus: The company's focus on online sales provides a scalable business model.
RLLVF Healthcare Stock FAQ
What do analysts say about RLLVF stock?
As of March 17, 2026, there is no readily available analyst coverage or consensus on Relevium Technologies Inc. (RLLVF) stock. Given its OTC listing and small market capitalization, the stock may not be widely followed by analysts.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is based on the most recently available information.
- Analyst consensus is not available due to limited coverage.
- OTC market data may be less reliable than data from major exchanges.